Pharmaceutical Fine Chemicals Market by Drug Type (Proprietary, Non-Proprietary), Product (Basic Building Blocks, Advanced Intermediates, Active Ingredients), Application (Cardiovascular, Neurological, Oncological, Respiratory, Gastrointestinal, Musculoskeletal), and Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America), Global Forecasts 2018 to 2028
Aug 2020
Total Pages: 119
Choose License Type
Global Pharmaceutical Fine Chemicals accounted for a market size of around USD 93 billion in the year 2019 and is projected to grow at a CAGR of more than 6% over the forecast period. Fine chemicals are pure substances, which are blended with basic chemicals to transform into complex chemicals, owing to which the product has high specification adding to its price. The chemicals are used in the different healthcare fields such as pharmaceuticals, and nutraceuticals. The positive outlook across these industries is augmenting the product demand.
The global Pharmaceutical Fine Chemicals market size is projected to reach over USD 157 billion by 2028. The rising geriatric population coupled with growing health awareness among consumers and the increasing number of cases for chronic diseases is expected to drive the product demand in the coming years. Furthermore, the utilization of chemicals across the agricultural industry to increase the yield of crops is further contributing to the growth of the industry.
.png "Global Pharmaceutical Fine Chemicals Market 2018-2028 (USD Billion)")
The COVID-19 situation posed a little impact on the pharmaceutical fine chemicals industry. The fine chemicals witnessed a surge in demand only from the healthcare sector as other sectors announced a halt in operations. During the initial phase of the outbreak, the demand took a hit as doctor priority was to treat coronavirus infected patients. Although, the steady opening of the lockdown restrictions along with the reopening of medical facilitates for treatment of various illnesses is expected to escalate the demand for the fine chemicals. Furthermore, rising awareness for attaining improved health conditions is further expected to escalate the growth in the post-COVID period.
Key segments across Pharmaceutical Fine Chemicals market
- Drug Type Overview, 2018 – 2028 (USD Billion and kilotons)
- Proprietary
- Non-Proprietary
- Product Overview, 2018 – 2028 (USD Billion and kilotons)
- Basic Building Blocks
- Advanced Intermediates
- Active Ingredients
- Application Overview, 2018 – 2028 (USD Billion and kilotons)
- Cardiovascular
- Neurological
- Oncological
- Respiratory
- Gastrointestinal
- Musculoskeletal
- Others
- Regional Overview, 2018 – 2028 (USD Billion and kilotons
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
• Middle East & Africa
o Saudi Arabia
o Rest of Middle East & Africa
• South America
o Brazil
o Rest of South America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
• Middle East & Africa
o Saudi Arabia
o Rest of Middle East & Africa
• South America
o Brazil
o Rest of South America
Reasons for the study
- The purpose of the study is to give an exhaustive outlook of the global Pharmaceutical Fine Chemicals industry. Benchmark yourself against the rest of the market.
- Be prepared for how Pharmaceutical Fine Chemicals industry investments will be impacted by socio-political and economic factors over the next few years.
- Ensure you remain competitive as new innovations by existing key players boost the market.
What does the report include?
- The study on the global Pharmaceutical Fine Chemicals includes qualitative factors such as drivers, restraints, and opportunities.
- The study covers the competitive landscape of existing/prospective players in the industry and their strategic initiatives for the form development.
- The study covers a qualitative and quantitative analysis of the market segmented on the basis of drug type, products, and application. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments.
Who should buy this report?
This study is suitable for industry participants and stakeholders in the global Pharmaceutical Fine Chemicals. The report will benefit:
- Every stakeholder involved in manufacturing and distributing components or solutions.
- Managers within financial institutions looking to publish recent and forecasted statistics pertaining to the global Pharmaceutical Fine Chemicals industry.
- Government organizations, regulatory authorities, policymakers and financial organizations looking for T&D investment trends in global Pharmaceutical Fine Chemicals industry.
- Analysts, researchers, educators, strategy managers, and academic institutions looking for insights into the market to determine future strategies.
The pharmaceutical fine chemicals are witnessing an upsurge in demand owing to increasing awareness toward maintaining health and ill-effects of chemical products. Positive government outlook along with the introduction of regulatory norms is stimulating the industry size. For instance, the raw material used for the preparation of the chemicals is administered by the Food and Drug Administration (FDA). The organization has established different standards for the products manufactured from the chemicals. The industry is characterized by industry players focusing on research & development (R&D) activities. The rising demand for chemicals owing to the diverse applications is expected to stimulate the business upsurge.
Drug Type Segment
In terms of drug type, the market is bifurcated into proprietary, and non-proprietary segments. The proprietary segment is estimated to hold a major market share over the forecast period. The market growth of this segment is ascribed to the rising utilization of technologies by industry participants to manufacture drugs that are effective as well as cost-competitive.
Product Segment
On the basis of the product segment, the market is distributed into basic building blocks, advanced intermediates, and active ingredients. The active ingredient is analyzed to hold the largest market share in comparison to other products on account of demand for high purity, and quality products.
-2018–2028.png "Global Pharmaceutical Fine Chemicals Market by Product (Active Ingredient) 2018–2028")
Application Segment
Based on the application, the market is segmented into cardiovascular, neurological, oncological, respiratory, gastrointestinal, and musculoskeletal. The cardiovascular segment is anticipated to witness a significant growth rate over the forecast years. These chemicals are used to manufacture drugs for the treatment of blood vessels and heart diseases.
In terms of geography, the global Pharmaceutical Fine Chemicals is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is anticipated to dominate the global Pharmaceutical Fine Chemicals market. The region comprises strict regulations for manufacturing and consumption. The region is further characterized by increase in awareness for drug use and consumer inclination toward preventive healthcare, which in turn, has upheld the product demand.
The leading players operating across the global Pharmaceutical Fine Chemicals market include Denisco Chemicals, Albemarle Corporation, Kenko Corporation, W. R. Grace & Co., Chemada Fine Chemicals, Syntor Fine Chemicals, Johnson Matthey Fine Chemicals, and Pfizer Inc. The market for Pharmaceutical Fine Chemicals is consolidated with established global players and is further witnessing the emergence of new industry players Moreover, the industry players are targeting toward enhancing their market share through implementation of merger & acquisition, collaboration growth strategies.
Global Pharmaceutical Fine Chemicals accounted for a market size of around USD 93 billion in the year 2019 and is projected to grow at a CAGR of more than 6% over the forecast period. Fine chemicals are pure substances, which are blended with basic chemicals to transform into complex chemicals, owing to which the product has high specification adding to its price. The chemicals are used in the different healthcare fields such as pharmaceuticals, and nutraceuticals. The positive outlook across these industries is augmenting the product demand.
The global Pharmaceutical Fine Chemicals market size is projected to reach over USD 157 billion by 2028. The rising geriatric population coupled with growing health awareness among consumers and the increasing number of cases for chronic diseases is expected to drive the product demand in the coming years. Furthermore, the utilization of chemicals across the agricultural industry to increase the yield of crops is further contributing to the growth of the industry.
The COVID-19 situation posed a little impact on the pharmaceutical fine chemicals industry. The fine chemicals witnessed a surge in demand only from the healthcare sector as other sectors announced a halt in operations. During the initial phase of the outbreak, the demand took a hit as doctor priority was to treat coronavirus infected patients. Although, the steady opening of the lockdown restrictions along with the reopening of medical facilitates for treatment of various illnesses is expected to escalate the demand for the fine chemicals. Furthermore, rising awareness for attaining improved health conditions is further expected to escalate the growth in the post-COVID period.
Key segments across Pharmaceutical Fine Chemicals market
- Drug Type Overview, 2018 – 2028 (USD Billion and kilotons)
- Proprietary
- Non-Proprietary
- Product Overview, 2018 – 2028 (USD Billion and kilotons)
- Basic Building Blocks
- Advanced Intermediates
- Active Ingredients
- Application Overview, 2018 – 2028 (USD Billion and kilotons)
- Cardiovascular
- Neurological
- Oncological
- Respiratory
- Gastrointestinal
- Musculoskeletal
- Others
- Regional Overview, 2018 – 2028 (USD Billion and kilotons
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
• Middle East & Africa
o Saudi Arabia
o Rest of Middle East & Africa
• South America
o Brazil
o Rest of South America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
• Middle East & Africa
o Saudi Arabia
o Rest of Middle East & Africa
• South America
o Brazil
o Rest of South America
Reasons for the study
- The purpose of the study is to give an exhaustive outlook of the global Pharmaceutical Fine Chemicals industry. Benchmark yourself against the rest of the market.
- Be prepared for how Pharmaceutical Fine Chemicals industry investments will be impacted by socio-political and economic factors over the next few years.
- Ensure you remain competitive as new innovations by existing key players boost the market.
What does the report include?
- The study on the global Pharmaceutical Fine Chemicals includes qualitative factors such as drivers, restraints, and opportunities.
- The study covers the competitive landscape of existing/prospective players in the industry and their strategic initiatives for the form development.
- The study covers a qualitative and quantitative analysis of the market segmented on the basis of drug type, products, and application. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments.
Who should buy this report?
This study is suitable for industry participants and stakeholders in the global Pharmaceutical Fine Chemicals. The report will benefit:
- Every stakeholder involved in manufacturing and distributing components or solutions.
- Managers within financial institutions looking to publish recent and forecasted statistics pertaining to the global Pharmaceutical Fine Chemicals industry.
- Government organizations, regulatory authorities, policymakers and financial organizations looking for T&D investment trends in global Pharmaceutical Fine Chemicals industry.
- Analysts, researchers, educators, strategy managers, and academic institutions looking for insights into the market to determine future strategies.
Chapter 1 Introduction
1.1 Introduction to the Study
1.2 Market Definition and Scope
1.3 Key Stakeholders
1.4 Key Questions Answered
Chapter 2 Research Methodology
2.1 Introduction
2.2 Data Capture Sources
2.2.1 Primary Sources
2.2.2 Secondary Sources
2.3 Market Size Estimation
2.4 Market Forecast
2.5 Data Triangulation
2.6 Assumptions and Limitations
Chapter 3 Executive Summary
Chapter 4 Market Outlook
4.1 Introduction
4.2 Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.4 Porter’s Five Forces Analysis
4.5 PEST Analysis
Chapter 5 Pharmaceutical Fine Chemicals Market by Drug Type
5.1 Introduction
5.1.1 Proprietary
5.1.2 Non-Proprietary
Chapter 6 Pharmaceutical Fine Chemicals Market by Product
6.1 Introduction
6.1.1 Basic building blocks
6.1.2 Advanced Intermediates
6.1.3 Active Ingredients
Chapter 7 Pharmaceutical Fine Chemicals Market by Applications
7.1 Introduction
7.1.1 Cardiovascular
7.1.2 Neurological
7.1.3 Oncological
7.1.4 Respiratory
7.1.5 Gastrointestinal
7.1.6 Musculoskeletal
7.1.7 Others
Chapter 8 Pharmaceutical Fine Chemicals Market By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 UK
8.3.2 Germany
8.3.3 Italy
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Rest of Asia Pacific
8.5 Middle East & Africa
8.5.1 Saudi Arabia
8.5.2 Rest of Middle East & Africa
8.6 South America
8.6.1 Brazil
8.6.2 Rest of South America
Chapter 9 Competitive Landscape
9.1 Overview
9.2 Strategic Initiatives
9.2.1 Acquisition
9.2.2 Joint Venture
9.2.3 Agreement
Chapter 10 Company Profiles
10.1 Denisco Chemicals
10.1.1 Overview
10.1.2 Products and Services Portfolio
10.1.3 Recent Initiatives
10.1.4 Financial Analysis
10.1.5 SWOT Analysis
10.2 Albemarle Corporation
10.2.1 Overview
10.2.2 Products and Services Portfolio
10.2.3 Recent Initiatives
10.2.4 Financial Data
10.2.5 SWOT Analysis
10.3 Kenko Corporation
10.3.1 Overview
10.3.2 Products and Services Portfolio
10.3.3 Recent Initiatives
10.3.4 Financial Data
10.3.5 SWOT Analysis
10.4 W. R. Grace & Co.
10.4.1 Overview
10.4.2 Products and Services Portfolio
10.4.3 Recent Initiatives
10.4.4 Financial Data
10.4.5 SWOT Analysis
10.5 Chemada Fine Chemicals
10.5.1 Overview
10.5.2 Products and Services Portfolio
10.5.3 Financial Data
10.5.4 Recent Initiatives
10.5.5 SWOT Analysis
10.6 Syntor Fine Chemicals
10.6.1 Overview
10.6.2 Products and Services Portfolio
10.6.3 Financial Data
10.6.4 Recent Initiatives
10.6.5 SWOT Analysis
10.7 Johnson Matthey Fine Chemicals
10.7.1 Overview
10.7.2 Products and Services Portfolio
10.7.3 Financial Data
10.7.4 Recent Initiatives
10.7.5 SWOT Analysis
10.8 Pfizer Inc
10.8.1 Overview
10.8.2 Products and Services Portfolio
10.8.3 Financial Data
10.8.4 Recent Initiatives
10.8.5 SWOT Analysis
10.9 GlaxoSmithKline plc
10.9.1 Overview
10.9.2 Products and Services Portfolio
10.9.3 Financial Data
10.9.4 Recent Initiatives
10.9.5 SWOT Analysis
10.10 Other Companies
Chapter 11 Appendix
11.1 Primary Research Approach
11.1.1 Primary Interview Participants
11.1.2 Primary Interview Summary
11.2 Questionnaire
11.3 Related Report List
11.4 Published
11.5 Upcoming